HHM Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

HHM Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$991	Hold	100	–	–	﹤0.01%	833
2026 Q1	$613	Hold	100	–	–	﹤0.01%	844
2025 Q4	$831	Hold	100	–	–	﹤0.01%	804
2025 Q3	$1.46K	Hold	100	–	–	﹤0.01%	796
2025 Q2	$1.13K	Hold	100	–	–	﹤0.01%	804
2025 Q1	$570	Hold	100	–	–	﹤0.01%	874
2024 Q4	$982	Buy	100 +20	+25%	+$171	﹤0.01%	858
2024 Q3	$652	Hold	80	–	–	﹤0.01%	740
2024 Q2	$1.07K	Hold	80	–	–	﹤0.01%	735
2024 Q1	$3.71K	Buy	80 +25	+45%	+$1.29K	﹤0.01%	648
2023 Q4	$3.72K	Hold	55	–	–	﹤0.01%	651
2023 Q3	$3.98K	Hold	55	–	–	﹤0.01%	663
2023 Q2	$4.09K	Buy	55 +27	+96%	+$1.6K	﹤0.01%	679
2023 Q1	$1.46K	Hold	28	–	–	﹤0.01%	749
2022 Q4	$1.86K	Hold	28	–	–	﹤0.01%	614
2022 Q3	$3K	Hold	28	–	–	﹤0.01%	570
2022 Q2	$3K	Hold	28	–	–	﹤0.01%	704
2022 Q1	$4K	Buy	+28	New	+$5.45K	﹤0.01%	627

Other funds holding DNA

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BSWM

Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

CAL

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

ATC

Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

HHM Wealth Advisors's DNA Position: Q2 2026 in Review

HHM Wealth Advisors held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 100 shares worth $991. The position accounts for ﹤0.01% of the portfolio, ranked #833.

HHM Wealth Advisors first reported a position in DNA in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.09K in Q2 2023. 11 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

HHM Wealth Advisors held 100 shares of Ginkgo Bioworks worth $991 as of Q2 2026.
HHM Wealth Advisors left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #833 holding.
HHM Wealth Advisors first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 18 quarters since.
HHM Wealth Advisors's Ginkgo Bioworks position peaked at $4.09K in Q2 2023.
11 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.